Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies.
about
Beyond Adoption: A New Framework for Theorizing and Evaluating Nonadoption, Abandonment, and Challenges to the Scale-Up, Spread, and Sustainability of Health and Care Technologies.The Bright Elusive Butterfly of Value in Health Technology Development: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies".New Health Technologies: A UK Perspective Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies".The Conceptualization of Value in the Value Proposition of New Health Technologies: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies".Why Learning How to Chase Butterflies Matters: A Response to Recent Commentaries.Analysing the role of complexity in explaining the fortunes of technology programmes: empirical application of the NASSS framework.
P2860
Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Providing Value to New Health ...... tors, and Regulatory Agencies.
@en
type
label
Providing Value to New Health ...... tors, and Regulatory Agencies.
@en
prefLabel
Providing Value to New Health ...... tors, and Regulatory Agencies.
@en
P2093
P2860
P356
P1476
Providing Value to New Health ...... tors, and Regulatory Agencies.
@en
P2093
Fiona A Miller
Geneviève Daudelin
Jean-Louis Denis
P2860
P304
P356
10.15171/IJHPM.2017.11
P577
2017-01-25T00:00:00Z